Press Releases China Medical System Holdings Limited

Equities

867 KYG211081248

Market Closed - Hong Kong S.E. Other stock markets 04:08:27 2024-07-12 am EDT			5-day change	1st Jan Change
6.61 ^HKD	+2.48%		-1.34%	-52.24%

Jun. 25	China Medical System Holdings Limited Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China	CI
Jun. 18	China Medical System Gets Drug Registration Certificate for Lesion Visualization Drug in China	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China	Jun. 25	AQ
Cosmo's oral diagnostic drug Lumeblue receives approval of New Drug Application in China	Jun. 19	AQ
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China	Jun. 18	AQ
China Medical System: New Drug Application of Desidustat Tablets Accepted in China	Apr. 23	AQ
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia	Apr. 01	AQ
China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs	Mar. 27	AQ
China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®	Feb. 03	AQ
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA	Jan. 02	AQ
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL	Dec. 13	AQ
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China	Dec. 04	AQ
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug	23-08-24	AQ
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management	23-07-31	AQ
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global	23-06-29	AQ
Sun Pharma Announces China NMPA Approval for ILUMETRI for Treatment of Adults with Moderate-To-Severe Plaque Psoriasis	23-05-31	AQ
China Medical System : Voluntary and Business Update Announcement Achieving Collaboration with OVMEDI for the Embedding Thread Product	21-12-14	PU
China Medical System : Monthly Return of Equity Issuer on Movements in Securities	21-05-07	PU
China Medical System : Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation	21-04-26	AQ
China Medical System : Voluntary and Business Update Announcement Equity investment in and Establishment of a Joint Venture with Trinomab	21-04-19	PU
China Medical System (0867.HK): Accelerating Development and Stepping to a New Height Driven by Innovation	21-04-02	AQ
China Medical System : PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND, GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	21-03-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases China Medical System Holdings Limited

Equities

867

KYG211081248

Press Releases

Filters